Este trabalho foi financiado pelos Institutos Nacionais de Saúde (DP1CA174426 para Carlos F. Barbas) e da Universidade ShanghaiTech, Shanghai, China (a JL). Gráficos moleculares foram gerados utilizando pymol.

1. Clonagem <ol><li> Obter de dois dedos domínios ZIF substituído por alanina que foram sub-clonados no sistema de expressão vector pET-28 e estão disponíveis mediante pedido (PET-2F-ZiF). 34 </li><li> EmGFP amplificar por PCR a partir do plasmídeo pBAD-esmeralda com os iniciadores 5 &#39;Xmal-EmGFP (3-ATGGTGAGCAAGGGCGAGGAGCTGTTCAC 5&#39;-GGAAATTG CCCGGG&#39;; sítio Xmal em negrito) e 3 &#39;Saci-EmGFP (5&#39;-CGGATCT GAGCTC TTACTTGTACAGCTCGTCCATGCCGAG-3&#39; site eu Sac em negrito);. <ol><li> Use 5 ng de ADN molde, 10 ul de tampão de polimerase 10x, 1 Unidades (U) de Taq DNA polimerase, 0,2 mM de cada dNTP e 0,2 pM de cada iniciador numa solução de 100 uL com o restante volume constituídos de água destilada / desionizada . Use as condições dos ciclos: 95 ° C durante 5 min; 30 ciclos de 95 ° C durante 30 seg, 55 ° C durante 30 seg e 72 ° C durante 1 min; 72 ° C durante 10 min. Purifica-se o produto de PCR por gel extractie em determinar a concentração de ADN utilizando um espectrofotómetro de medição Abs 260 x 50 ug / ml. </li></ol></li><li> Digest pET-2F-ZiF e a inserção que codifica EmGFP com as enzimas de restrição Xmal e Sac I em tampão recomendado durante 3 horas a 37 ° C utilizando 10 U de enzima por 1 ug de ADN. Visualizar o ADN por electroforese em gel de agarose, utilizando um corante fluorescente intercalante, tal como brometo de etídio. </li><li> Purifica-se o ADN digerido por gel extraction kit e determinar a concentração de DNA por um espectrofotómetro Abs medindo 260 x 50 ug / ml. </li><li> Ligadura o ADN que codifica EmGFP purificado em 50-100 ng de pET-2F-ZiF usando 1 U de T4 DNA ligase durante pelo menos 1 h à TA. Para melhores resultados, realizar a reacção de ligação utilizando uma razão de 6: molar de inserção-para-um vector. </li><li> Descongelar 50 ul de quaisquer células XL-1 azul de E. coli quimicamente competentes de Escherichia em gelo e misturar suavemente com 10-20 ng de ligado pET-2F-ZiF-EmGFP. </li><li> Manter em gelo durante 30 min. O choque térmico a mistura a 42 ° C durante 90 seg e recuperar as células em 2 ml de caldo super óptima com repressão catabólica (SOC) durante 1 hora a 37 ° C com agitação. </li><li> Espalhe 100 ul de cultura de recuperação em um caldo lisogenia (LB) placa de ágar com 50 ug / ml de canamicina e incubar O / N a 37 ° C. </li><li> No dia seguinte, inocula 6 ml de Super Broth (SB) ou cultura LB contendo 50 ug / ml de canamicina com uma colónia da placa de agar LB e a cultura O / N a 37 ° C. Nota: Colony PCR utilizando os iniciadores 5 &#39;e Xmal-EmGFP 3&#39; Saci-EmGFP poderia ser usado para identificar os clones positivos antes de miniprep. </li><li> Purificar pET-2F-ZiF-EmGFP por miniprep e confirmar plasmídeo por sequenciação de ADN utilizando o promotor de T7 (5&#39;-TAATACGACTCACTATAGGG-3 &#39;). </li></ol> 2. Expressão e purificação <ol><li> Descongelar 50 ul de quimicamente competentes BL21 de E. coli células no gelo e misture delicadamente com 100 ng do PET-2F-ZiF-EmGFP plasmid. Transformação como descrito nos passos 1,7-1,8. </li><li> No dia seguinte, inocular 10 ml de meio LB contendo 50 ug / ml de canamicina com uma única colónia e crescer O / N a 37 ° C com agitação. </li><li> No dia seguinte, dilui-se os 10 ml da cultura D / N para 1 L de meio LB suplementado com 50 ug / ml de canamicina, 0,2% de glucose e 100 mM de ZnCl2. Crescer a cultura a 37 ° C com agitação até uma densidade óptica a 600 nm (OD 600) de 0,8 e induzir a expressão da proteína com 2 mM de isopropil-β-D-1-tiogalactopiranósido (IPTG). Após 6 horas de crescimento a 37 ° C, as células da colheita por centrifugação a 5000 xg durante 10 min a 4 ° C. Nota: As condições de indução são muito variáveis ​​e dependem da estabilidade das proteínas a ser expressa. Monitorar a OD a 600 a cada 30 min até uma DO600 de 0,8 seja alcançado. </li><li> Ressuspender o sedimento celular em 5 ml de tampão de lise (50 mM Tris-HCl, 500 mM de NaCl, 100 mM de ZnCl2, 1 mM ditiotreitol (DTT), 1 mM de MgCl 2, 1 mM de fluoreto de fenilmetilsulfonilo (PMSF) e 10 mM de imidazol, pH 8,0). Lisar as células no gelo por ultra-sons com a seguinte configuração: 50% de potência, 4 min de tempo de processo com 5 sec on / off intervalos de 10 segundos. Evitar o sobreaquecimento da solução. </li><li> Centrifuga-se o lisado celular a 25000 xg durante 30 min a 4 ° C e transferir o sobrenadante para um tubo de recolha de fresco. Para melhores resultados, executar todos os passos seguintes a 4 ° C. </li><li> Executar o sobrenadante através de uma coluna pré-embalada com 1 ml de suspensão equilibrada de Ni-NTA. Lava-se a resina com 20 ml de tampão de lavagem (50 mM Tris-HCl, 500 mM de NaCl, 100 fiM de ZnCl2, 1 mM de DTT, 1 mM de MgCl 2 e 30 mM de imidazol, pH 8,0). </li><li> Elui-se a proteína com 5 ml de tampão de eluição (50 mM Tris-HCl, 500 mM de NaCl, 100 fiM de ZnCl2, 1 mM de DTT, 1 mM de MgCl2, e 300 mM de imidazole, pH 8,0). </li><li> Tampão de trocar a proteína eluída com tampão de armazenamento (50 mMTris-HCl, 500 mM de NaCl, 100 mM de ZnCl2, 1 mM de DTT, 1 mM de MgCl2 e glicerol a 10%, pH 8,0) e concentrar a proteína de pelo menos 40 jiM utilizando um concentrador de rotação por centrifugação de acordo com as instruções do fabricante. </li><li> Determinar a concentração de proteína pelo ensaio de Bradford ou BCA. Misturar 2 ul de proteínas purificadas com 2 ul 2 × SDS-PAGE de corante de carga, ferver a 95 ° C durante 10 min e em seguida resolver a 4% -20% de Tris-Glicina SDS-PAGE para avaliar a pureza de proteína (Figura 2). </li></ol> 3. Proteína de armazenamento <ol><li> Alíquota da proteína concentrada, congelamento de flash em nitrogênio líquido e armazenar a -80 ° C. Para as proteínas de fusão EmGFP, cobrir o tubo com folha de alumínio para proteger a proteína da luz. </li><li> Evite congelamento e descongelamento da solução de proteína repetido. Nota: ZiF proteínas fundidas são estáveis ​​sob estas condições durante pelo menos 1 mês. Ou armazenamento inadequado mês&gt; 4 pode levara precipitação de proteínas ou de fotobranqueamento EmGFP. </li></ol> Transdução 4. Protein <ol><li> Manter as células HeLa em meio de Eagle modificado por Dulbecco (DMEM) contendo 10% (v / v) de soro fetal bovino (FBS) e 1% de antibiótico-antimicótico a 37 ° C em uma atmosfera totalmente humidi ficada com 5% de CO 2. Nota: As células passadas mais de 30 vezes não são recomendados para a transdução de proteína. </li><li> Pré-revestimento de uma placa de 24 poços com 500 ul de 50 ug / ml de poli-lisina para 30 a 60 min a 25 ° C. Semear as células num prato de 24 cavidades a uma densidade de 2 x 10 5 células por poço. Em 24 horas após a sementeira, ou uma vez que as células são entre 80% -90% confluentes, retirar o suporte de cada poço e lava-se com 500 ul de DMEM isento de soro pré-aquecido (SFM). </li><li> Para cada poço, adicione 250 mL de SFM contendo 2 uM de proteína ZiF-EmGFP e 100 uM de ZnCl2. Incubar as células a 37 ° C durante 1 h. Nota: domínios ZIF entrar nas células primarily através de macropinocitose, 34, o qual é um mecanismo dependente de energia. Portanto, as células devem ser incubados a 37 ° C durante internalização proteína eficiente. </li><li> Remover meios a partir de células e lava-se três vezes com 500 ul de cálcio e sem magnésio salina tamponada com fosfato de Dulbecco (DPBS) suplementado com 0,5 mg / ml de heparina. Nota: A heparina é necessário remover a proteína ligada à superfície que pode complicar análises a jusante. </li><li> (Opcional) tratamentos repetidos até três vezes para maior entrega. </li><li> Isolar células tratadas imediatamente depois de heparina de lavagem por digestão com 0,05% de tripsina-EDTA a 37 ° C durante 2 min. Re-suspender as células isoladas em 0,5 ml de DPBS suplementadas com 1% de FBS. </li><li> Medir a intensidade de fluorescência de cada amostra por 35 citometria de fluxo utilizando o isotiocianato de fluoresceína (FITC) canal (Figura 3). Ajuste a dispersão para a frente (FSC) e dispersão lateral (SSC) para colocar a população deinteresse na escala, assegurando que as populações com propriedades diferentes são resolvidos um do outro. </li><li> Colete 10.000 eventos ao vivo para cada amostra e analisar os dados utilizando citometria de fluxo de análise de dados software. 36 Normalize fluorescência de células HeLa tratadas com ZiF-EmGFP a essas células tratadas apenas com SFM. </li></ol>

<ol>
	<li>Berg, A., Dowdy, S. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+transduction+domain+delivery+of+therapeutic+macromolecules.">Protein transduction domain delivery of therapeutic macromolecules.</a> Curr. Opin. Biotechnol. 22, 888-893 (2011).</li><li>Lindsay, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Peptide-mediated+cell+delivery:+application+in+protein+target+validation.">Peptide-mediated cell delivery: application in protein target validation.</a> Curr. Opin. Pharmacol. 2, 587-594 (2002).</li><li>Luo, D., Saltzman, W. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Synthetic+DNA+delivery+systems.">Synthetic DNA delivery systems.</a> Nat. Biotechnol. 18, 33-37 (2000).</li><li>Guo, X., Huang, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recent+advances+in+nonviral+vectors+for+gene+delivery.">Recent advances in nonviral vectors for gene delivery.</a> Acc. Chem. Res. 45, 971-979 (2012).</li><li>Thomas, C. E., Ehrhardt, A., Kay, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Progress+and+problems+with+the+use+of+viral+vectors+for+gene+therapy.">Progress and problems with the use of viral vectors for gene therapy.</a> Nat. Rev. Genet. 4, 346-358 (2003).</li><li>Frankel, A. D., Pabo, C. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cellular+uptake+of+the+tat+protein+from+human+immunodeficiency+virus.">Cellular uptake of the tat protein from human immunodeficiency virus.</a> Cell. 55, 1189-1193 (1988).</li><li>Elliott, G., O'Hare, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intercellular+trafficking+and+protein+delivery+by+a+herpesvirus+structural+protein.">Intercellular trafficking and protein delivery by a herpesvirus structural protein.</a> Cell. 88, 223-233 (1997).</li><li>Derossi, D., Joliot, A. H., Chassaing, G., Prochiantz, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+third+helix+of+the+Antennapedia+homeodomain+translocates+through+biological+membranes.">The third helix of the Antennapedia homeodomain translocates through biological membranes.</a> J. Biol. Chem. 269, 10444-10450 (1994).</li><li>Smith, B. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Minimally+cationic+cell-permeable+miniature+proteins+via+alpha-helical+arginine+display.">Minimally cationic cell-permeable miniature proteins via alpha-helical arginine display.</a> J. Am. Chem. Soc. 130, 2948-2949 (2008).</li><li>Daniels, D. S., Schepartz, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intrinsically+cell-permeable+miniature+proteins+based+on+a+minimal+cationic+PPII+motif.">Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif.</a> J. Am. Chem. Soc. 129, 14578-14579 (2007).</li><li>Karagiannis, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rational+design+of+a+biomimetic+cell+penetrating+peptide+library.">Rational design of a biomimetic cell penetrating peptide library.</a> ACS Nan. 7, 8616-8626 (2013).</li><li>Gao, S., Simon, M. J., Hue, C. D., Morrison, B., 3r, S., Banta, <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+unusual+cell+penetrating+peptide+identified+using+a+plasmid+display-based+functional+selection+platform.">An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.</a> ACS Chem. Biol. 6, 484-491 (2011).</li><li>Fuchs, S. M., Raines, R. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Arginine+grafting+to+endow+cell+permeability.">Arginine grafting to endow cell permeability.</a> ACS Chem. Biol. 2, 167-170 (2007).</li><li>Cronican, J. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Potent+delivery+of+functional+proteins+into+mammalian+cells+in+vitro+and+in+vivo+using+a+supercharged+protein.">Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein.</a> ACS Chem. Biol. 5, 747-752 (2010).</li><li>Panyam, J., Labhasetwar, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biodegradable+nanoparticles+for+drug+and+gene+delivery+to+cells+and+tissue.">Biodegradable nanoparticles for drug and gene delivery to cells and tissue.</a> Adv. Drug Deliv. Rev. 55, 329-347 (2003).</li><li>Zelphati, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intracellular+delivery+of+proteins+with+a+new+lipid-mediated+delivery+system.">Intracellular delivery of proteins with a new lipid-mediated delivery system.</a> J. Biol. Chem. 276, 35103-35110 (2001).</li><li>Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H., Chatterjee, D. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+delivery+using+engineered+virus-like+particles.">Protein delivery using engineered virus-like particles.</a> Proc. Natl. Acad. Sci. U. S. A. 108, 16998-17003 (2011).</li><li>Voelkel, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+transduction+from+retroviral+Gag+precursors.">Protein transduction from retroviral Gag precursors.</a> Proc. Natl. Acad. Sci. U. S. A. 107, 7805-7810 (2010).</li><li>Sinha, V. R., Trehan, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biodegradable+microspheres+for+protein+delivery.">Biodegradable microspheres for protein delivery.</a> J. Control Release. 90, 261-280 (2003).</li><li>Liu, J., Gaj, T., Patterson, J. T., Sirk, S. J., Barbas, C. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cell-penetrating+peptide-mediated+delivery+of+TALEN+proteins+via+bioconjugation+for+genome+engineering.">Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering.</a> PLoS One. 9, e85755 (2014).</li><li>Ramakrishna, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+disruption+by+cell-penetrating+peptide-mediated+delivery+of+Cas9+protein+and+guide+RNA.">Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.</a> Genome Res. 24, 1020-1027 (2014).</li><li>Fuchs, S. M., Raines, R. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Polyarginine+as+a+multifunctional+fusion+tag.">Polyarginine as a multifunctional fusion tag.</a> Protein Sci. 14, 1538-1544 (2005).</li><li>Mai, J. C., Shen, H., Watkins, S. C., Cheng, T., Robbins, P. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficiency+of+protein+transduction+is+cell+type-dependent+and+is+enhanced+by+dextran+sulfate.">Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate.</a> J. Biol. Chem. 277, 30208-30218 (2002).</li><li>Al-Taei, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intracellular+traffic+and+fate+of+protein+transduction+domains+HIV-1+TAT+peptide+and+octaarginine.+Implications+for+their+utilization+as+drug+delivery+vectors.">Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.</a> Bioconjug. Chem. 17, 90-100 (2006).</li><li>Jones, S. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterisation+of+cell-penetrating+peptide-mediated+peptide+delivery.">Characterisation of cell-penetrating peptide-mediated peptide delivery.</a> Br. J. Pharmacol. 145, 1093-1102 (2005).</li><li>Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., Gregory, P. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Genome+editing+with+engineered+zinc+finger+nucleases.">Genome editing with engineered zinc finger nucleases.</a> Nat. Rev. Genet. 11, 636-646 (2010).</li><li>Carroll, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Genome+engineering+with+zinc-finger+nucleases.">Genome engineering with zinc-finger nucleases.</a> Genetics. 188, 773-782 (2011).</li><li>Guo, J., Gaj, T., Barbas, C. F., 3rd, <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Directed+evolution+of+an+enhanced+and+highly+efficient+FokI+cleavage+domain+for+zinc+finger+nucleases.">Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases.</a> J. Mol. Biol. 400, 96-107 (2010).</li><li>Gaj, T., Guo, J., Kato, Y., Sirk, S. J., Barbas, C. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeted+gene+knockout+by+direct+delivery+of+zinc-finger+nuclease+proteins.">Targeted gene knockout by direct delivery of zinc-finger nuclease proteins.</a> Nat. Methods. 9, 805-807 (2012).</li><li>Gersbach, C. A., Gaj, T., Barbas, C. F., 3rd, <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Synthetic+zinc+finger+proteins:+the+advent+of+targeted+gene+regulation+and+genome+modification+technologies.">Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.</a> Acc. Chem. Res. 47, 2309-2318 (2014).</li><li>Gaj, T., Gersbach, C. A., Barbas, C. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=ZFN,+TALEN,+and+CRISPR/Cas-based+methods+for+genome+engineering.">ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.</a> Trends Biotechnol. 31, 397-405 (2013).</li><li>Perez-Pinera, P., Ousterout, D. G., Gersbach, C. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Advances+in+targeted+genome+editing.">Advances in targeted genome editing.</a> Curr. Opin. Chem. Biol. 16, 268-277 (2012).</li><li>Cronican, J. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+class+of+human+proteins+that+deliver+functional+proteins+into+mammalian+cells+in+vitro+and+in+vivo.">A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.</a> Chem. Biol. 18, 833-838 (2011).</li><li>Gaj, T., Liu, J., Anderson, K. E., Sirk, S. J., Barbas, C. F., 3rd, <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+delivery+using+Cys2-His2+zinc-finger+domains.">Protein delivery using Cys2-His2 zinc-finger domains.</a> ACS Chem. Biol. 9, 1662-1667 (2014).</li><li>Radcliff, G., Jaroszeski, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Basics+of+flow+cytometry.">Basics of flow cytometry.</a> Methods Mol. Biol. 91, 1-24 (1998).</li><li>Mercer, A. C., Gaj, T., Sirk, S. J., Lamb, B. M., Barbas, C. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulation+of+endogenous+human+gene+expression+by+ligand-inducible+TALE+transcription+factors.">Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors.</a> ACS Synth. Biol. 3, 723-730 (2014).</li><li>Segal, D. J., Crotty, J. W., Bhakta, M. S., Barbas, C. F., Horton, N. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structure+of+Aart,+a+designed+six-finger+zinc+finger+peptide,+bound+to+DNA.">Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA.</a> J. Mol. Biol. 363, 405-421 (2006).</li></ol>

Os autores não têm nada a revelar.

Aqui, um protocolo passo-a-passo para a entrega de proteína utilizando dedo de zinco (ZiF) domínios de células-permeável é apresentado. O domínio ZiF não reduz a atividade de carga enzimática fundido 34; permite a produção e purificação de proteínas em rendimentos quase idênticos aos observados com a proteína não modificada; e pode transportar proteínas e enzimas para uma ampla gama de tipos de células, com as eficiências que excedem os sistemas tradicionais de penetração de células de péptido ou de proteína de domínio de transdução. Juntos, estes resultados indicam o amplo potencial de domínios Zif para mediar a entrega directa de proteínas em células de uma vasta gama de aplicações. O débito máximo de proteína foi anteriormente conseguida utilizando apenas um domínio ZiF de dois dedos, apesar do facto de que se estendia matrizes de três e quatro domínios dedo-Zif transportam maior carga positiva. Estes resultados indicam que a entrada na célula ZiF mediada pode ser influenciado por outros que carga, inc factoresluding a estabilidade da proteína ou rigidez conformacional. Entrega proteína ZiF domínio mediada também foi encontrada para ser dependente de energia e, assim, requer que todas as células tratadas com a proteína ser incubadas a 37 ° C. Através do uso de inibidores de moléculas pequenas de várias vias de endocitose, macropinocitose, e em menor grau dependente da caveolin endocitose, foram determinadas como sendo as principais vias para a entrada na célula ZiF-mediada. 34 Em particular, ao contrário de outros sistemas de transdução de proteína, os domínios são ZiF capaz de escapar para mediar eficientemente endossomas níveis elevados de entrega citosólica da carga macromolecular fundido, ressaltando o potencial destes domínios para conseguir a entrega de proteína robusto. Em nossa experiência, a densidade de semeadura de células é um passo fundamental para alcançar altos níveis de transdução de proteína. Recomendamos tratamento de células, uma vez que chegar a 80% -90% de confluência e anteriormente observado que células semeadas em&gt; 95% de confluência espetáculo sub-capacidade de transdução óptimo, enquanto que as células semeadas em densidades baixas (&lt;50%) são susceptíveis à toxicidade induzida por proteína. Importante, para tipos de células com altos tendências de descolamento, placas de cultura de células pré-revestidas com poli-lisina são recomendados. Poli-lisina facilita a fixação das células através de interacções electrostáticas com os componentes da superfície da célula carregada negativamente. Embora os resíduos de ligação ao ADN de hélice α de cada domínio ZiF ter sido removida para eliminar qualquer possibilidade de reconhecimento de DNA, os resíduos de cisteína e histidina que coordenam com o ião Zn2 + para estabilizar a dobra domínio ΒΒα ZiF permanecem intactos. Assim, recomenda-se que qualquer tampão de armazenamento, ser suplementado com, pelo menos, 100 uM de ZnCl 2 para manter a integridade da proteína. Embora o domínio ZiF foi anteriormente mostrado para administrar proteínas e enzimas para uma variedade de tipos de células, a eficiência de entrega ZiF também pode ser dependente da tanto macromoléculaslecular carga e concentração de proteína. Por exemplo, as células tratadas com dois dedos ZiF-proteína de fusão de luciferase foram observados a exibir luminescência máxima quando tratada com 0,5 fiM de proteína, com a diminuição da actividade a concentrações mais elevadas, enquanto que as células tratadas com dois dedos EmGFP exibiu um aumento dependente da dose na fluorescência intensidade até 8,0 proteína? M, e sobre tratamentos de proteína consecutivos. Recomendamos, portanto, avaliar a célula penetrante capacidade de cada domínio de fusão única ZiF através de uma gama de concentrações. Finalmente, embora ainda não demonstrou, prevemos que a entrega de domínio ZiF é uma plataforma altamente flexível, capaz de fornecer uma gama diversificada de macromoléculas em células. Por exemplo, pode ser possível, tanto no DNA e RNA para ser funcionalizados quimicamente sobre a superfície do domínio ZiF hidrolisável através de um ligante, ou transfectadas transientemente em células por encapsulação de Zif domínios. Além disso, o efficirência de entrega proteína ZiF poderá ser reforçada por esforços de design racionais com foco em otimização de carga de superfície.

Altamente estratégias de fornecimento de proteína eficientes e versáteis são críticos para muitos pesquisa básica e aplicações terapêuticas. A entrega directa das proteínas purificadas em células representa um dos métodos mais seguros e mais fáceis para alcançar este objectivo. 1,2 Ao contrário das estratégias que dependem de expressão de genes de ácidos nucleicos, 3-5 entrega proteína não apresenta nenhum risco de mutagénese de inserção, é independente do transcrição / máquinas e tradução celular permite um efeito imediato. No entanto, a falta de métodos simples e generalizáveis ​​para dotar a atividade de penetração celular para proteínas confunde rotineiramente sua entrada direta nas células. Os métodos actuais para facilitar a entrega intracelular de proteínas são baseadas no uso de ocorrência natural ou 6-8 concebidos de penetração de células, péptidos 9-12 domínios de transdução de sobrealimentação, 13,14 nanopartículas 15, 16 e lipossomas partículas semelhantes a vírus 17,18 </sup&gt; e materiais de microesferas poliméricas. 19 Infelizmente, muitas dessas abordagens são dificultados pelas taxas de captação celular baixos, 20,21 pobre estabilidade, 22 inadvertida tipo de célula de especificidade, 23 propriedades de escape baixo endossomais 24 e toxicidade. 25 Além disso, muitos proteína tecnologias de transdução de reduzir a bioactividade das proteínas entregues 14. O nosso laboratório demonstrou anteriormente que zinc-finger nuclease proteínas (ZFN) - endonucleases de restrição quimérico que consiste de uma Cys His 2 2 zinc-finger programável proteína de ligação a ADN e domínio de clivagem da endonuclease de restrição FokI 26-28 - são inerentemente célula.dia permeável. 29 Esta actividade de penetração celular surpreendente mostrou ser uma propriedade intrínseca do domínio dedo-de-zinco personalizados, com uma plataforma de ligação de ADN que surgiu como uma ferramenta poderosa para o genoma segmentado enengenha-, 30-32 e ser considerada como o resultado da constelação de seis resíduos carregados positivamente na superfície da proteína. De facto, várias proteínas de ligação de ADN, incluindo c-Jun e N-DEK foram mostrados para possuir uma capacidade inata para atravessar as membranas celulares. 33 Mais recentemente, no nosso laboratório expandido estes resultados e demonstraram que a actividade da célula de penetração de zinco finger (ZIF) da domínios poderia ser aproveitado para a entrega de proteínas intracelulares. Fusão genética de ambos domínios ZIF de um ou dois dedos para carga proteína específica levou a absorção eficiências que superaram muitos sistemas de entrega de peptídeos convencionais de penetração celular. 34 Mais notavelmente, entrega ZiF mediada não comprometeu a atividade de carga enzimática fundido e facilitado altos níveis de entrega cytosolic. Colectivamente, estes resultados demonstram o potencial do domínio ZiF para facilitar a entrega eficiente e fácil de proteínas, e potencialmente mais diversos tipos de macromoléculas, em células. Aqui, um protocolo detalhado passo-a-passo sobre como implementar a tecnologia ZiF para entrega de proteína em células de mamíferos é apresentada. Nós previamente construído um conjunto de um, dois, três, quatro, cinco e seis domínios dedo-Zif que não possuem a capacidade de se ligar ao ADN, devido a substituição de cada um dos resíduos de ligação ao ADN de hélice α, mas são capazes de fornecer proteínas em células 34 (Figura 1). A produção e a transdução de esmeralda GFP (EmGFP) em células HeLa usando um domínio ZiF de dois dedos é descrito. Este protocolo é extensível para quase qualquer proteína solúvel capaz de expressão em Escherichia coli e quase qualquer tipo de células de mamíferos. Os resultados esperados são fornecidos e estratégias para maximizar o desempenho do sistema também são discutidos.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>XmaI</td>
			<td>New England Biolabs</td>
			<td>R0180L</td>
			<td></td>
		</tr>
		<tr>
			<td>SacI</td>
			<td>New England Biolabs</td>
			<td>R0156L</td>
			<td></td>
		</tr>
		<tr>
			<td>Expand High Fidelity PCR system</td>
			<td>Roche</td>
			<td>11759078001</td>
			<td></td>
		</tr>
		<tr>
			<td>dNTPs</td>
			<td>New England Biolabs</td>
			<td>N0446S</td>
			<td></td>
		</tr>
		<tr>
			<td>4-20% Tris-Glycine Mini protein gels, 1.5 mm, 10 wells</td>
			<td>Life Technologies</td>
			<td>EC6028BOX</td>
			<td></td>
		</tr>
		<tr>
			<td>2x Laemmli Sample Buffer</td>
			<td>BioRad</td>
			<td>161-0737</td>
			<td></td>
		</tr>
		<tr>
			<td>T4 DNA Ligase</td>
			<td>Life Technologies</td>
			<td>15224-017</td>
			<td></td>
		</tr>
		<tr>
			<td>BL21 (DE3) Competent E. coli</td>
			<td>New England Biolabs</td>
			<td>C2527I</td>
			<td></td>
		</tr>
		<tr>
			<td>IPTG</td>
			<td>Thermo Scientific</td>
			<td>R0391</td>
			<td></td>
		</tr>
		<tr>
			<td>Zinc Chloride</td>
			<td>Sigma-Aldrich</td>
			<td>208086-5G</td>
			<td></td>
		</tr>
		<tr>
			<td>Kanamycin Sulfate</td>
			<td>Fisher Scientific</td>
			<td>BP906-5</td>
			<td></td>
		</tr>
		<tr>
			<td>Glucose</td>
			<td>Sigma-Aldrich</td>
			<td>G8270-100G</td>
			<td></td>
		</tr>
		<tr>
			<td>Tris Base</td>
			<td>Fisher Scientific</td>
			<td>BP152-25</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium Chloride</td>
			<td>Sigma-Aldrich</td>
			<td>S9888-25G</td>
			<td></td>
		</tr>
		<tr>
			<td>DTT</td>
			<td>Fisher Scientific</td>
			<td>PR-V3151&#160;</td>
			<td></td>
		</tr>
		<tr>
			<td>PMSF</td>
			<td>Thermo Scientific</td>
			<td>36978</td>
			<td></td>
		</tr>
		<tr>
			<td>Ni-NTA Agarose Resin</td>
			<td>QIAGEN</td>
			<td>30210</td>
			<td></td>
		</tr>
		<tr>
			<td>Glycerol</td>
			<td>Sigma-Aldrich</td>
			<td>G5516-500ML</td>
			<td></td>
		</tr>
		<tr>
			<td>Imidazole</td>
			<td>Sigma-Aldrich</td>
			<td>I5513-25G</td>
			<td></td>
		</tr>
		<tr>
			<td>Amicon Ultra-15 Centrifugal Filter Units</td>
			<td>EMO Millipore</td>
			<td>UFC900324</td>
			<td></td>
		</tr>
		<tr>
			<td>DMEM</td>
			<td>Life Technologies</td>
			<td>11966-025</td>
			<td></td>
		</tr>
		<tr>
			<td>Fetal Bovine Serum</td>
			<td>Life Technologies</td>
			<td>10437-028</td>
			<td></td>
		</tr>
		<tr>
			<td>Antibiotic-Antimycotic&#160;</td>
			<td>Life Technologies</td>
			<td>15240-062</td>
			<td></td>
		</tr>
		<tr>
			<td>24-Well Flat Bottom Plate</td>
			<td>Sigma-Aldrich</td>
			<td>CLS3527-100EA</td>
			<td></td>
		</tr>
		<tr>
			<td>Poly-Lysine</td>
			<td>Sigma-Aldrich</td>
			<td>P7280</td>
			<td></td>
		</tr>
		<tr>
			<td>DPBS, No Calcium, No Magnesium</td>
			<td>Life Technologies</td>
			<td>21600010</td>
			<td></td>
		</tr>
		<tr>
			<td>Heparan Sulfate</td>
			<td>Sigma-Aldrich</td>
			<td>H4777</td>
			<td></td>
		</tr>
		<tr>
			<td>Trypsin</td>
			<td>Life Technologies</td>
			<td>25300054</td>
			<td></td>
		</tr>
		<tr>
			<td>Hela cells</td>
			<td>ATCC</td>
			<td>CCL-2</td>
			<td></td>
		</tr>
		<tr>
			<td>Nano Drop ND-1000 spectrophotometer&#160;</td>
			<td>Thermo Fisher Scientific</td>
			<td>N/A</td>
			<td></td>
		</tr>
		<tr>
			<td>QIAquick PCR Purification Kit</td>
			<td>QIAGEN</td>
			<td>28104</td>
			<td></td>
		</tr>
		<tr>
			<td>QIAquick Gel Extraction Kit</td>
			<td>QIAGEN</td>
			<td>28704</td>
			<td></td>
		</tr>
	</tbody>
</table>

direct protein delivery to mammalian cells using cell-permeable cys2-his2 zinc-finger domains

Due to their modularity and ability to be reprogrammed to recognize a wide range of DNA sequences, Cys2-His2 zinc-finger DNA-binding domains have emerged as useful tools for targeted genome engineering. Like many other DNA-binding proteins, zinc-fingers also possess the innate ability to cross cell membranes. We recently demonstrated that this intrinsic cell-permeability could be leveraged for intracellular protein delivery. Genetic fusion of zinc-finger motifs leads to efficient transport of protein and enzyme cargo into a broad range of mammalian cell types. Unlike other protein transduction technologies, delivery via zinc-finger domains does not inhibit enzyme activity and leads to high levels of cytosolic delivery. Here a detailed step-by-step protocol is presented for the implementation of zinc-finger technology for protein delivery into mammalian cells. Key steps for achieving high levels of intracellular zinc-finger-mediated delivery are highlighted and strategies for maximizing the performance of this system are discussed.

Dois dedos de proteínas de fusão ZiF-EmGFP pode ser expresso em E. coli com&gt; 95% de homogeneidade e rendimentos elevados (&gt; 25 mg / ml) (Figura 2). Em geral, de um e de dois dedos proteínas de fusão ZiF pode ser produzido em quantidades quase idênticas às de proteína não modificada tipo selvagem. No entanto, em alguns contextos, as proteínas de fusão ZiF cinco e seis dedos não são capazes de ser produzidos em rendimentos elevados o suficiente para aplicações a jusante. A aplicação directa de dois dedos proteína ZiF-EmGFP em células HeLa, durante 90 min a 37 ° C conduz a um aumento dose-dependente na EmGFP fluorescência (Figura 3A). Fundamentalmente, qualquer fluorescência é observado na ausência do domínio ZiF. Observou-se anteriormente que quase 100% de células são fluorescentes após tratamento com apenas 2 uM de dois dedos proteína ZiF-EmGFP, e que as células HeLa tratadas com a proteína de fusão ZiF são positivas para fluorescência EmGFP em concentrações proteicas<html> tão baixo quanto 0.25 uM (Figura 3B). <img alt="Figura 1" src="/files/ftp_upload/52814/52814fig1.jpg" /> Figura 1. Estrutura e seqüência de proteína zinc-finger. Estrutura (Superior) de cristal de um domínio de dedo de zinco única (ZiF). As cadeias laterais de Cys conservado e resíduos His coordenados com o ião Zn2 + são mostrados como varas (PDB ID: 2I13). 37 (parte inferior) da sequência do domínio ZiF. Setas e cilindros indicam estruturas secundárias Β folhas e α-hélice, respectivamente. Os resíduos de ligação ao ADN de hélice α que foram substituídos com alanina são destacadas rosa. Resíduos carregados positivamente previstos para mediar a internalização celular são destacadas azul claro. <a href="https://www-jove-com.remotexs.ntu.edu.sg/files/ftp_upload/52814/52814fig1large.jpg" target="_blank">Por favor, clique aqui para ver uma versão maior desta figura.</a> &quot;Fo: manter-together.within-page =&quot; always &quot;&gt; <img alt="Figura 2" src="/files/ftp_upload/52814/52814fig2.jpg" /> Figura 2. SDS-PAGE de purificado de um, dois, três e quatro dedos proteínas de fusão ZiF-EmGFP. Proteínas de fusão ZiF-EmGFP foram expressos em E. coli e purificado por meio de resina de Ni-NTA agarose. Proteína eluída foi analisada quanto à pureza por SDS-PAGE utilizando um 4% -20% de gel de Tris-Glicina. Não foi observada qualquer degradação significativa ou truncagens de proteínas de fusão ZiF-EmGFP. <img alt="Figura 3" src="/files/ftp_upload/52814/52814fig3.jpg" /> Figura 3. ZiF entrega mediada por proteína em células HeLa. (A) da intensidade da fluorescência de células HeLa tratadas com quantidades crescentes de dois dedos proteína ZiF-EmGFP. Células HeLa tratadas com proteína EmGFP sozinho sobrepõem totalmente com células não tratadas. (B) a intensidade de fluorescência de células HeLa Normalizada tratados consecutivamente com 2 uM of dois dedos proteína ZiF-EmGFP. A intensidade da fluorescência foi determinada por citometria de fluxo.

Watch this Scientific Journal Video about Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains at JoVE.com

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains

Domínios dedo-de-zinco são intrinsecamente célula-permeável e capaz de mediar a entrega de proteína em uma ampla gama de tipos de células de mamíferos. Aqui, um protocolo detalhado passo-a-passo para a implementação da tecnologia de dedo de zinco para a entrega intracelular de proteínas é apresentada.

Entrega Protein direto para células de mamíferos utilizando células-permeável Cys<sub&gt; 2</sub&gt; -His<sub&gt; 2</sub&gt; Domínios zinc-finger

Due to their modularity and ability to be reprogrammed to recognize a wide range of DNA sequences, Cys2-His2 zinc-finger DNA-binding domains have emerged ...

direct-protein-delivery-to-mammalian-cells-using-cell-permeable-cys2

Nanyang Technological University

Research

JoVE Journal

Biology

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains

9.8K visualizações.  The Scripps Research Institute.  Domínios dedo-de-zinco são intrinsecamente célula-permeável e capaz de mediar a entrega de proteína em uma ampla gama de tipos de células de mamíferos. Aqui, um protocolo detalhado passo-a-passo para a implementação da tecnologia de dedo de zinco para a entrega intracelular de proteínas é apresentada. 

Vídeo: Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains

Long-term Imaging Mammalian Cells using Wide-Field Microscopy

Actually what I'm gonna do, mount it in here first and then swap out You. So now I'm gonna aspirate try and be as gentle as possible.Okay. A few seconds just holding.Okay.Alright.So the important features of our lifestyle imaging grid are that, so it's an inverted scope, which means the objective, the samples here in the objective is underneath. So the objective is pointing up and the whole scope, or practically the whole, practically the whole scope, including the objectives and the sample are at 37 degrees. So everything in this plastic box is at 37 degrees.And right on top of the stage we have an air and CO2 mix. That is 5%CO2. So the idea is that the sample is actually in a cell, it's like a cell incubator.And so we have, this is our mixer for the air and the CO2 and, and it gets humidified and heated and then piped onto the, the sample on the stage.Okay. And today we're just gonna be doing fluorescence one channel GFP fluorescence. This is the hose that the CO2 and 5%CO2 goes in and it just fits into the stage holder.That's important. And then we can close these, take these down, and then we go to our first position. And what I'm gonna do is go to the first field, which is my control sample, and I'll pick positions based on what I see on the screen.So I just make sure I actually look into the microscope in each new, well, because the focal plane for each of the wells is different, the, the dish is not perfectly flat on the bottom. So you will need to make fine adjustments when you move from well to the well. So right now I'm on the first, well, what I'll do is I'll focus, so I just hit, I just told, I just turned on the light, the transmitted light for the microscope.And I have make sure all the light is going to the eye pieces. And so I just look in, make sure I get a nice clean field. And then what I'll do is turn that light off, turn the fluorescence light on, make sure the cells that I'm looking at look healthy and they're not apoptotic.And, and I turn that off. And what I do next is send, so now I'm gonna start picking positions, which means I have to te send the light path to the camera. This is the camera right here.So I tell the microscope to send all the camera, they don't see anything in the eye pieces. What I'll do is in the software controlling the microscope, I'll choose the right filter set, which for our purposes is psy. And then set an exposure time.And I know these cells very well and I know that they take a 0.2 second exposure time. So I tell, that's what I tell the software to do. And what I'll do is hit focus.This is, and it's basically just alive. The, A light will turn on and you can, oh, I don't know if you can see cells, but the reason this is a good field is because there's, all the cells are, even in terms of their fluorescence, There are no apoptotic cells. Apoptotic cells tend to be very bright and there's no dirt or schmutz in the field.And you can see that they're actually, this is a metaphase cell and that's a metaphase cell, that's a cell that's probably just exited mitosis. And I can just tell that because it looks like those are, those two sets of chromatin are very nicely oriented to each other. Like they just exited an face.So that's a good field. So, and now that I know that the exposure time and the filter set is correct, and this is gonna be software specific, I'll go and I'll take positions and now the software has memorized the X, Y, Z position of that field. And then when I do pick another field, it's, and I'll, so when I'm picking, when I'm picking new fields, but in the same, well, I'll use the, I'll move the i'll, I'll turn the shutter, I'll open the shutter and I'll look to see what I see on the screen and I'll pick fields based on that versus looking in the field.So I don't see any of my tonics in there. But again, even nicely centered, these cells will go through my PS I continue, here's a good example. Here's a good example of what I would avoid that, see how bright that is?That's very bright. That's probably remnants of an apoptotic cell. And the reason I would avoid that is because since it's so bright, when the software auto focuses, it will autofocus just on that and it won't be in the same plane as all these other cells.And so I won't get any information from that field. That looks nice. There's a, this is a pro metaphase right here, That's A metaphase.So, and I'm gonna take three positions per well. So that was three positions and now I'm going to go to my next Well, so you can, so what I will probably do is take images every 10 minutes. So it's a compromise.Lifestyle imaging is always a compromise, right? You have to image, you have to keep the cells healthy, especially if you're interested in mitosis. So you have to minimize their exposure to the fluorescent line.And, but you wanna get information. So you have to take images, you have to, so you have to compromise, you have to make a choice about what you want to capture, what kind of information you wanna capture. For our purposes, mitosis tends to take about an hour.So if we're taking 10 minute intervals, that's pretty good. We see prophase, we see metaphase, we see anaphase, and we can, we can see when there are, there are treatments or drugs or siRNAs that affect those specific cell cycle stages. So for our purposes, that's enough, but we always want more.We always want more positions or finer time and interval or something like that. So it's a compromise. So, and then I'll hit start.And so our software, it does an autofocusing pass on the first pass. So once I hit start, it should start auto autofocusing and you'll see the shutter open, open and close between auto focusing. So I'll hit start.So that's the shutter opening and closing. The Z motor is engaging and it's actually trying to find the plane with the most contrast, which will be the most in focus. You can actually see on the screen going in and out of finding the best plane of focus that might be worrisome.So what it does is it, it drives the Z motor to find the best, the most in focus plane focus, well the most in image. And then it acquires picture there and then it learns that Z position. And then we'll use that Z position for the next 12 passes.And then we'll do the auto focusing pass again. What Kind of experiments do they do? Okay, so our lab is mostly interested in understanding what regulates mitic progression, or at least I'm most interested in understanding that.So with live cell imaging and especially our multi position, long-term imaging scope, you can take, you can film cells for two or three days entering anding mitosis, and you can image multiple rounds of mitosis so you can understand. And then you can put drugs or RNAs or any kind of perturbations on the cells that you would like to study. So you can understand how, how those drugs or, or genes are, are important in regulating mitotic progression.Because it's not fixed cell work and live cell work, you can understand what, when you need to have a perturbation to affect mitosis or what stage of mitosis is affected. So it's really powerful in that respect. What, what are the main technical elements of this experiments?What are the possible problems? Well, the biggest problem besides getting the rig set up, getting the rig set up is not trivial. A lot of people have the rig, but just making sure it works well for your application.The financial element is not, you know, is not small. So there's the setting up of the apparatus and then, and then once you gather the data, there's a real data analysis issue. It takes these movie, if, so, if you're gathering 40 movies each with 30 cells, so you have 40 in 40 fields that you just filmed and each of those fields has 30 cells, then you have to sit down with each one of those movies and look at each one of those cells in that movie.So it takes a really long time to do data analysis. And that's, so it takes a week to analyze data that it took you two days to collect. So there's a, that's a very big obstacle in terms of gathering lots of data.So it's not, while it's high throughput data collection, it's not high throughput analysis. So what would you make to make this experiment really high throughput? So our lab is in the process of developing a program that does the data analysis automatically.And it's a pretty decent program. It's not perfect. The human eye is always better, but it's getting there.So What are the interesting application of this experiment? Maybe other fields you can mention? Besides cell division?You mean for the, oh, for the live cell imaging? Yes.Well, you can do cell motility assays. You can, depending on the, the microscopy that's involved, you can, you know, look at how cells, you could look at tumor development if you really wanted to.But there, you, you're, if as long as you have the right imaging set up, you can, you're pretty much not limited in terms of anything. Our scope happens to be just a wide field and we use 20 by 20 x objective. So it's a pretty low resolution set up, but that's sufficient for what we need to see.So there are, but there definitely aren't, you wouldn't be limited. Anything that has any dynamic kind of experiment, which is biology, it would be, would really benefit from lifestyle imaging. So calcium imaging, although you couldn't do it on our apparatus, that's a live cell.You definitely need live cell imaging for that. Like I said, patient assays, motility assays, those kinds of things would really benefit from live cell imaging. Would you like to tell a few words about your previous experience?How long do you work on these techniques? What do you you work on before? Wow.So in my PhD I didn't work.I did a lot of confocal microscopy, but no lifestyle imaging. And so during my postdoc I was, I helped Dr.King get this apparatus that, that we just used to set up these fragment, get that up and running. And, and so during my postdoc, I had a lot of experience with both widefield with TimeLapse imaging on our scope, which is the widefield and also TimeLapse imaging with confocal microscopy.And I would say that it's really powerful. You get a lot of information, but it's not easy to get working perfectly. So it really requires a lot of attention and a lot of attention to details at every little step of the process.And, and then you still have problems. So it's a tough application, but you can really get, if, if it's what you need to have to, to study your problem, your scientific problem, then it, it's invaluable in that respect, but it's tough. So find someone who knows what they're doing and use them.That's my advice. So good.

Longo prazo células de mamíferos utilizando imagens do Largo-Campo Microscopia

Biologia

Trypsinizing and Subculturing Mammalian Cells

As cells reach confluency, they must be subcultured or passaged. Failure to subculture confluent cells results in reduced mitotic index and eventually in cell death. The first step in subculturing is to detach cells from the surface of the primary culture vessel by trypsinization or mechanical means. The resultant cell suspension is then subdivided, or reseeded, into fresh cultures. Secondary cultures are checked for growth and fed periodically, and may be subsequently subcultured to produce tertiary cultures. The time between passaging of cells varies with the cell line and depends on the growth rate.

As cells reach confluency, they must be subcultured or passaged. This video will demonstrate a procedure for subculturing both adherent and suspension cells.

Trypsinizing e Subcultura células de mamíferos

As cells reach confluency, they must be subcultured or passaged. Failure to subculture confluent cells results in reduced mitotic index and eventually in ...

Engineering Cell-permeable Protein

The protein transduction technique enables the direct delivery of biologically active material into mammalian cells [for review see 1,2]. For this one can make use of the translocating ability of so-called cell penetrating peptides (CPPs), also designated as protein transduction domains (PTDs). The TAT-CPP derived from the human immunodeficiency virus type 1 (HIV-1) Tat (trans-activator of transcription) protein has been widely used. The positively charged TAT promotes cell permeability thereby overcoming the barriers of the cellular membrane by endocytosis or/and direct membrane penetration2. In combination with a nuclear localization signal (NLS) fusion proteins are able to enter the nucleus exhibiting functionality. Our video presentation demonstrates, as an exemplification for the engineering of cell-permeable proteins, the construction, production and application of a cell-permeable version of the DNA-modifying enzyme Cre.
Cre is a site-specific recombinase that is able to recognize and recombine 34 base pair loxP sites in mammalian cells in vitro and in vivo. Therefore the Cre/loxP system is widely used to conditionally induce mutations in the genome of living cells3,4. The delivery of active Cre recombinase to cells, however, represents a limitation.
We describe the pSESAME vector system, which allows a direct insertion of the gene-of-interest and provides a platform to rapidly clone different domains and tags used within the vector in a convenient and standardized manner. Rearranging of the different tags has been shown to modify the biochemical properties of the fusion proteins providing a possibility to achieve higher yield and better solubility. We demonstrate how to express and purify recombinant cell-permeant proteins in and from E. coli. The functionality of the recombinant Cre protein is finally validated in cell culture by assessing its intracellular recombinase activity.

Protein transduction enables the direct delivery of biologically active proteins into cells. In contrast to conventional methods such as DNA transfection or viral transduction this non-invasive paradigm allows highly efficient cellular manipulation in a titratable manner circumventing cellular toxicity and the risk of oncogenic transformation by permanent genetic modification.

Engenharia de Proteínas Cell-permeáveis

The protein transduction technique enables the direct delivery of biologically active material into mammalian cells [for review see 1,2]. For this one can ...

Using the GELFREE 8100 Fractionation System for Molecular Weight-Based Fractionation with Liquid Phase Recovery

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based fractionation. The system is comprised of single-use, 8-sample capacity cartridges and a benchtop GELFREE Fractionation Instrument. During separation, a constant voltage is applied between the anode and cathode reservoirs, and each protein mixture is electrophoretically driven from a loading chamber into a specially designed gel column gel. Proteins are concentrated into a tight band in a stacking gel, and separated based on their respective electrophoretic mobilities in a resolving gel. As proteins elute from the column, they are trapped and concentrated in liquid phase in the collection chamber, free of the gel. The instrument is then paused at specific time intervals, and fractions are collected using a pipette. This process is repeated until all desired fractions have been collected. If fewer than 8 samples are run on a cartridge, any unused chambers can be used in subsequent separations.
This novel technology facilitates the quick and simple separation of up to 8 complex protein mixtures simultaneously, and offers several advantages when compared to previously available fractionation methods. This system is capable of fractionating up to 1mg of total protein per channel, for a total of 8mg per cartridge. Intact proteins over a broad mass range are separated on the basis of molecular weight, retaining important physiochemical properties of the analyte. The liquid phase entrapment provides for high recovery while eliminating the need for band or spot cutting, making the fractionation process highly reproducible1.

The accompanying video describes the use of the GELFREE 8100 Fractionation System, which partitions complex protein samples on the basis of molecular weight and recovers the fractions in liquid phase. The video describes how the technology works, how it is used, and provides resultant data, with polyacrylamide gel electrophoresis analysis of fractionated bovine liver homogenate.

Usando o sistema de fracionamento GELFREE 8100 para Fracionamento baseada no peso molecular com Recovery Fase Líquida

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based ...

Genome Editing with CompoZr Custom Zinc Finger Nucleases (ZFNs)

Genome editing is a powerful technique that can be used to elucidate gene function and the genetic basis of disease. Traditional gene editing methods such as chemical-based mutagenesis or random integration of DNA sequences confer indiscriminate genetic changes in an overall inefficient manner and require incorporation of undesirable synthetic sequences or use of aberrant culture conditions, potentially confusing biological study. By contrast, transient ZFN expression in a cell can facilitate precise, heritable gene editing in a highly efficient manner without the need for administration of chemicals or integration of synthetic transgenes.
Zinc finger nucleases (ZFNs) are enzymes which bind and cut distinct sequences of double-stranded DNA (dsDNA). A functional CompoZr ZFN unit consists of two individual monomeric proteins that bind a DNA "half-site" of approximately 15-18 nucleotides (see Figure 1). When two ZFN monomers "home" to their adjacent target sites the DNA-cleavage domains dimerize and create a double-strand break (DSB) in the DNA.1 Introduction of ZFN-mediated DSBs in the genome lays a foundation for highly efficient genome editing. Imperfect repair of DSBs in a cell via the non-homologous end-joining (NHEJ) DNA repair pathway can result in small insertions and deletions (indels). Creation of indels within the gene coding sequence of a cell can result in frameshift and subsequent functional knockout of a gene locus at high efficiency.2 While this protocol describes the use of ZFNs to create a gene knockout, integration of transgenes may also be conducted via homology-directed repair at the ZFN cut site.
The CompoZr Custom ZFN Service represents a systematic, comprehensive, and well-characterized approach to targeted gene editing for the scientific community with ZFN technology. Sigma scientists work closely with investigators to 1) perform due diligence analysis including analysis of relevant gene structure, biology, and model system pursuant to the project goals, 2) apply this knowledge to develop a sound targeting strategy, 3) then design, build, and functionally validate ZFNs for activity in a relevant cell line. The investigator receives positive control genomic DNA and primers, and ready-to-use ZFN reagents supplied in both plasmid DNA and in-vitro transcribed mRNA format. These reagents may then be delivered for transient expression in the investigator&#x2019;s cell line or cell type of choice. Samples are then tested for gene editing at the locus of interest by standard molecular biology techniques including PCR amplification, enzymatic digest, and electrophoresis. After positive signal for gene editing is detected in the initial population, cells are single-cell cloned and genotyped for identification of mutant clones/alleles.

Genome Editing with CompoZr Custom Zinc Finger Nucleases ZFNs

The CompoZr Custom Zinc-Finger Nuclease (ZFN) Service enables precise genome editing in any organism or cell line at any locus defined by the user. This article describes the process for the design, manufacture, validation and implementation of the CompoZr Custom ZFN Service.

Genoma Edição com CompoZr personalizados Nucleases dedo de zinco (ZFNs)

Genome editing is a powerful technique that can be used to elucidate gene function and the genetic basis of disease. Traditional gene editing methods such ...

Investigating Protein-protein Interactions in Live Cells Using Bioluminescence Resonance Energy Transfer

Assays based on Bioluminescence Resonance Energy Transfer (BRET) provide a sensitive and reliable means to monitor protein-protein interactions in live cells. BRET is the non-radiative transfer of energy from a 'donor' luciferase enzyme to an 'acceptor' fluorescent protein. In the most common configuration of this assay, the donor is Renilla reniformis luciferase and the acceptor is Yellow Fluorescent Protein (YFP). Because the efficiency of energy transfer is strongly distance-dependent, observation of the BRET phenomenon requires that the donor and acceptor be in close proximity. To test for an interaction between two proteins of interest in cultured mammalian cells, one protein is expressed as a fusion with luciferase and the second as a fusion with YFP. An interaction between the two proteins of interest may bring the donor and acceptor sufficiently close for energy transfer to occur. Compared to other techniques for investigating protein-protein interactions, the BRET assay is sensitive, requires little hands-on time and few reagents, and is able to detect interactions which are weak, transient, or dependent on the biochemical environment found within a live cell. It is therefore an ideal approach for confirming putative interactions suggested by yeast two-hybrid or mass spectrometry proteomics studies, and in addition it is well-suited for mapping interacting regions, assessing the effect of post-translational modifications on protein-protein interactions, and evaluating the impact of mutations identified in patient DNA.

Interactions between proteins are fundamental to all cellular processes. Using Bioluminescence Resonance Energy Transfer, the interaction between a pair of proteins can be monitored in live cells and in real time. Furthermore, the effects of potentially pathogenic mutations can be assessed.

Investigando interações proteína-proteína em células vivas usando a transferência de Bioluminescência Resonance Energy

Assays based on Bioluminescence Resonance Energy Transfer (BRET) provide a sensitive and reliable means to monitor protein-protein interactions in live ...

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells

Post-translational modification of proteins with ubiquitin and ubiquitin-like molecules (UBLs) is emerging as a dynamic cellular signaling network that regulates diverse biological pathways including the hypoxia response, proteostasis, the DNA damage response and transcription.&#160; To better understand how UBLs regulate pathways relevant to human disease, we have compiled a human siRNA &#8220;ubiquitome&#8221; library consisting of 1,186 siRNA duplex pools targeting all known and predicted components of UBL system pathways. This library can be screened against a range of cell lines expressing reporters of diverse biological pathways to determine which UBL components act as positive or negative regulators of the pathway in question.&#160; Here, we describe a protocol utilizing this library to identify ubiquitome-regulators of the HIF1A-mediated cellular response to hypoxia using a transcription-based luciferase reporter.&#160; An initial assay development stage is performed to establish suitable screening parameters of the cell line before performing the screen in three stages: primary, secondary and tertiary/deconvolution screening. &#160;The use of targeted over whole genome siRNA libraries is becoming increasingly popular as it offers the advantage of reporting only on members of the pathway with which the investigators are most interested.&#160; Despite inherent limitations of siRNA screening, in particular false-positives caused by siRNA off-target effects, the identification of genuine novel regulators of the pathways in question outweigh these shortcomings, which can be overcome by performing a series of carefully undertaken control experiments.

Here, we describe a methodology to perform a targeted siRNA &#8220;ubiquitome&#8221; screen to identify novel ubiquitin and ubiquitin-like regulators of the HIF1A-mediated cellular response to hypoxia.&#160; This can be adapted to any biological pathway where a robust read out of reporter activity is available.

Screening siRNA identificar Ubiquitin e ubiquitina-como reguladores do sistema de caminhos biológicos em células de mamíferos cultivadas

Post-translational modification of proteins with ubiquitin and ubiquitin-like molecules (UBLs) is emerging as a dynamic cellular signaling network that ...

Identification of Protein Interaction Partners in Mammalian Cells Using SILAC-immunoprecipitation Quantitative Proteomics

Quantitative proteomics combined with immuno-affinity purification, SILAC immunoprecipitation, represent a powerful means for the discovery of novel protein:protein interactions. By allowing the accurate relative quantification of protein abundance in both control and test samples, true interactions may be easily distinguished from experimental contaminants. Low affinity interactions can be preserved through the use of less-stringent buffer conditions and remain readily identifiable. This protocol discusses the labeling of tissue culture cells with stable isotope labeled amino acids, transfection and immunoprecipitation of an affinity tagged protein of interest, followed by the preparation for submission to a mass spectrometry facility. This protocol then discusses how to analyze and interpret the data returned from the mass spectrometer in order to identify cellular partners interacting with a protein of interest. As an example this technique is applied to identify proteins binding to the eukaryotic translation initiation factors: eIF4AI and eIF4AII.

SILAC immunoprecipitation experiments represent a powerful means for discovering novel protein:protein interactions. By allowing the accurate relative quantification of protein abundance in both control and test samples, true interactions may be easily distinguished from experimental contaminants, and low affinity interactions preserved through use of less-stringent buffer conditions.

Identificação de parceiros de interação de proteínas em células de mamíferos utilizando SILAC-imunoprecipitação quantitativos Proteômica

Quantitative proteomics combined with immuno-affinity purification, SILAC immunoprecipitation, represent a powerful means for the discovery of novel ...

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

One major limitation with current human embryonic stem cell (ESC) differentiation protocols is the generation of heterogeneous cell populations.&#160;These cultures contain the cells of interest, but are also contaminated with undifferentiated ESCs, non-neural derivatives and other neuronal subtypes.&#160; This limits their use in in vitro and in vivo applications, such as in vitro modeling for drug discovery or cell replacement therapy. To help overcome this, reporter cell lines, which offer a means to visualize, track and isolate cells of interest, can be engineered.&#160;However, to achieve this in human embryonic stem cells via conventional homologous recombination is extremely inefficient.&#160;This protocol describes targeting of the Pituitary homeobox 3 (PITX3) locus in human embryonic stem cells using custom designed zinc-finger nucleases, which introduce site-specific double-strand DNA breaks, together with a PITX3-EGFP-specific DNA donor vector. Following the generation of the PITX3 reporter cell line, it can then be differentiated using published protocols for use in studies such as in vitro Parkinson&#8217;s disease modeling or cell replacement therapy.

Reporter cell lines offer a means to visualize, track and isolate cells of interest from heterogeneous populations.&#160;However, gene-targeting using conventional homologous recombination in human embryonic stem cells is extremely inefficient. Herein, we describe targeting CNS midbrain specific transcription factor PITX3 locus with EGFP using zinc-finger nuclease enhanced homologous recombination.

Zinc-finger nucleases Gene maior focalização em células estaminais embrionárias humanas

One major limitation with current human embryonic stem cell (ESC) differentiation protocols is the generation of heterogeneous cell ...

Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli

The production of recombinant membrane proteins for structural and functional studies remains technically challenging due to low levels of expression and the inherent instability of many membrane proteins once solubilized in detergents. A protocol is described that combines ligation independent cloning of membrane proteins as GFP fusions with expression in Escherichia coli detected by GFP fluorescence. This enables the construction and expression screening of multiple membrane protein/variants to identify candidates suitable for further investment of time and effort. The GFP reporter is used in a primary screen of expression by visualizing GFP fluorescence following SDS polyacrylamide gel electrophoresis (SDS-PAGE). Membrane proteins that show both a high expression level with minimum degradation as indicated by the absence of free GFP, are selected for a secondary screen. These constructs are scaled and a total membrane fraction prepared and solubilized in four different detergents. Following ultracentrifugation to remove detergent-insoluble material, lysates are analyzed by fluorescence detection size exclusion chromatography (FSEC). Monitoring the size exclusion profile by GFP fluorescence provides information about the mono-dispersity and integrity of the membrane proteins in different detergents. Protein: detergent combinations that elute with a symmetrical peak with little or no free GFP and minimum aggregation are candidates for subsequent purification. Using the above methodology, the heterologous expression in E. coli of SED (shape, elongation, division, and sporulation) proteins from 47 different species of bacteria was analyzed. These proteins typically have ten transmembrane domains and are essential for cell division. The results show that the production of the SEDs orthologues in E. coli was highly variable with respect to the expression levels and integrity of the GFP fusion proteins. The experiment identified a subset for further investigation.

Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli

A streamlined approach to screening for the expression of recombinant membrane proteins in Escherichia coli based on fusion to green fluorescent protein is presented.

Verde Fluorescente à base de proteínas Expressão Rastreio de Proteínas de Membrana em<em&gt; Escherichia coli</em

The production of recombinant membrane proteins for structural and functional studies remains technically challenging due to low levels of expression and ...